Related Experiment Video
Updated: Aug 7, 2026
10:37
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Advanced emphysema in African-American and white patients: do differences exist?
Wissam M Chatila1, Eric A Hoffman, John Gaughan
1Department of Radiology, University of Iowa Carver College of Medicine, Iowa City, USA. chatilw@temple.tuhs.edu
Chest
|July 15, 2006
Summary
African Americans with emphysema were younger and had similar lung impairment as white patients, despite smoking less. Radiographic analysis revealed less severe and differently distributed emphysema in African Americans.
Area of Science:
- Pulmonary Medicine
- Radiology
- Epidemiology
Background:
- Emphysema disproportionately affects white patients, with higher prevalence and mortality compared to African Americans.
- Existing epidemiological studies have not adequately explained these racial disparities in emphysema.
Purpose of the Study:
- To investigate racial differences in emphysema severity, anatomical distribution, and physiological impairments between white and African-American patients.
- To compare demographic, functional, and radiographic characteristics of emphysema in different racial groups.
Main Methods:
- Analysis of severe and very severe emphysema patients from the National Emphysema Treatment Trial.
- Comparison of patient demographics, pulmonary function (FEV1), gas exchange (PaO2), exercise capacity, and quality of life.
- Quantitative computed tomography (CT) scans to assess emphysema severity and distribution.
Main Results:
- African Americans (3.4%) were younger and smoked less than white patients (95%).
- No significant differences were observed in pulmonary function, gas exchange, or exercise capacity between racial groups.
- Radiographic analysis showed significantly less emphysema and a different distribution in African Americans compared to matched white patients.
Conclusions:
- African-American patients with emphysema present at a younger age with comparable lung impairment to white patients, despite lower smoking history.
- Quantitative radiographic analysis indicates distinct patterns in emphysema severity and distribution based on race.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History